الصفحة الرئيسية>>Androgen receptor antagonist 1

Androgen receptor antagonist 1

رقم الكتالوجGC60582

مضاد مستقبلات الأندروجين 1 هو أحد مضادات مستقبلات الأندروجين (AR) المتوفرة عن طريق الفم مع IC 50 من 59 نانومتريمكن استخدام مناهض مستقبلات الأندروجين 1 (المركب 6) في تركيب محطلات PROTAC AR ، والتي ينتج عنها تحلل بروتين AR بنسبة 24٪ و 47٪ في خلايا LNCaP عند 1 ميكرومتر و 10 ميكرومتر على التوالي

Products are for research use only. Not for human use. We do not sell to patients.

Androgen receptor antagonist 1 التركيب الكيميائي

Cas No.: 1338812-36-4

الحجم السعر المخزون الكميّة
5mg
417٫00
متوفر
10mg
742٫00
متوفر
25mg
1437٫00
متوفر
50mg
2178٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Androgen receptor antagonist 1 is an orally available full androgen receptor (AR) antagonist with an IC50 of 59 nM[1]. Androgen receptor antagonist 1 (Compound 6) can be used in the synthesis of PROTAC AR degraders, which results 24% and 47 % AR protein degradation in LNCaP cells at 1 μM and 10 μM, respectively[2].

Androgen receptor antagonist 1 (Compound 26; 1 nM-100 μM) shows significant cell growth inhibition effects for LNCaP and LNAR cells but not DU145 cells[1]. Cell Proliferation Assay[1] Cell Line: Prostate cancer (CaP) cells (LNCAP, LNAR, and DU145)

Androgen receptor antagonist 1 (Compound 26; 100 mg/kg once a day for 5 weeks) demonstrates excellent in vivo tumor growth inhibition upon oral administration in a castration-resistant prostate cancer (CRPC) animal model[1]. Animal Model: Male athymic nude mice with LNCaP xenograft model of CRPC[1]

[1]. Guo C, et al. Discovery of aryloxy tetramethylcyclobutanes as novel androgen receptor antagonists. J Med Chem. 2011 Nov 10;54(21):7693-704. [2]. Han X, et al. Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer. J Med Chem. 2019 Jan 24;62(2):941-964.

مراجعات

Review for Androgen receptor antagonist 1

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Androgen receptor antagonist 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.